FDA recall D-0016-2024

Central Admixture Pharmacy Services Inc · Class II · drug

Product

fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2081-1

Reason for recall

Lack of assurance of sterility:

Distribution

Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2023-09-21
Report date
2023-10-11
Termination date
2025-03-19
Voluntary/Mandated
Voluntary: Firm initiated
Location
San Diego, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0016-2024